Use this artifact to confirm MDR scope, including Annex XVI products, identify your economic operator role, and map a workable MDR route for CE marking, technical documentation, clinical evaluation, PMS, vigilance, UDI, EUDAMED, and legacy transition decisions.
MDR has applied since 26 May 2021. Legacy-device transition now depends on Article 120 conditions, the 26 May 2024 and 26 September 2024 cutoffs, and the staged EUDAMED rollout that makes the first four modules mandatory from 28 May 2026.
Run the MDR applicability testTrack application, transitional provisions, and operational milestones that affect certification planning, evidence readiness, and lifecycle obligations.
Use the decision flow to confirm scope, role, classification, and route assumptions, then identify the evidence you need across design, release, and post-market operations.
Deep dive pages for implementation planning, controls, reporting, and evidence.
EU Medical Device Regulation (MDR) Timeline and Decision Flow should be the shared entry point for your team. Route execution into Assessment Autopilot for live work and into SSOT when the artifact needs deeper research, evidence governance, or supporting analysis.
